SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurobiological Tech (NTII)
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
1494 40 0 NTII
Emcee:  Miles Rhyne Hoffman, CFA Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
844 Web Site about hCFR (the substance we are using in our XERECEPT(TM) Phase II TrJohn McCarthy-5/13/2000
843 Peritumoral brain edema ....... I am out of my league here ..... but the folloJohn McCarthy-5/13/2000
842 Just parking this here for future use ... virtualtrials.com regards, John McCJohn McCarthy-5/11/2000
841 John, that was very helpful. I hope you don't mind if I copy your post on tCraig S. Owens-5/10/2000
840 Craig - from one non-techie to another ...... It turns out - OUR HOUSE - hasJohn McCarthy-5/10/2000
839 Would someone please "translate" todays news for us non-technical typCraig S. Owens-5/9/2000
838 Peter ... <<re:reverse existing tolerance to the antinociceptive effectsJohn McCarthy-5/7/2000
837 John, >>Clinically available NMDA receptor antagonists memantine and dexBiomaven-5/7/2000
836 Other ATTRIBUTES of Memantine ....... >> Clinically available NMDA recepJohn McCarthy-5/6/2000
835 Thursday May 4, 10:06 am Eastern Time <<<< Statistical SignificanJohn McCarthy-5/4/2000
834 > What do you know about Allergan's Memantine Oral program? < Not mucCheryl Galt-5/4/2000
833 John & Cacaito: Thanks for your responses.BulbaMan-5/4/2000
832 Allergan has the rights to eye/retina indications, NTII gets nothing for this iCacaito-5/3/2000
831 BulbaMan .... Where? Here - just by luck ...... hon.ch Allergan and MemantinJohn McCarthy-5/2/2000
830 Memantine Reduces Diabetic Neuropathic Pain Reported by Patients in U.S. Trial John McCarthy-5/2/2000
829 John, Two questions: 1) How'd you find a copy of the advance press release?BulbaMan-5/1/2000
828 ADVANCE FOR RELEASE AT 6:00 P.M. EDT TUESDAY, MAY 2/ individual.com <<John McCarthy-4/29/2000
827 XERECEPT .... With the new $6.0 million + financing, NTII will re-initiate tesJohn McCarthy-4/28/2000
826 $5.30 per share! Very nice private placement. That means that the dilution was Dr. John M. de Castro-4/20/2000
825 Very important announcement today for NTII. This puts to rest any doubt that NTDr. John M. de Castro-4/19/2000
824 Two abstracts on memantine for Neuropathic Pain. The first is a beautiful pieceDr. John M. de Castro-4/15/2000
823 Friendly Advice to all NTII shareholders: Don't look at your portfolio todaCraig S. Owens-4/14/2000
822 If you go back to the Nov. 9, 1999, Form 13G filing, you'll see the originaJMarcus-4/12/2000
821 Lindsay Rosenwald is a highly successful and respected investor. He does a lot Dr. John M. de Castro-4/11/2000
820 Looks Like the Aries Fund added to the pot back in March. Somebody tell me if ICraig S. Owens-4/11/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News